Validity of the German version of the FCR-1r questionnaire in patients with urologic cancer [0.03%]
德国FCR-1r问卷在泌尿系统癌症患者中的有效性研究
Can Dümdüz,Sebastian Sage,Sofia Kugler et al.
Can Dümdüz et al.
Introduction Fear of Cancer Recurrence (FCR) is a prevalent and distressing issue for a significant proportion of cancer patients across various disciplines, yet it remains one of the most frequently unaddressed psychosocial needs. A key ba...
Efficacy and Safety of Prophylactic Tocilizumab in Patients with Multiple Myeloma Receiving Bispecific Antibodies: A Systematic Review and Meta-Analysis [0.03%]
托珠单抗预防治疗接受双特异性抗体的多发性骨髓瘤患者疗效和安全性的系统评价和meta分析
Angeline Tancherla,Fernando Dharmaraja,Andree Kurniawan
Angeline Tancherla
Background: Cytokine release syndrome (CRS) remains a major toxicity associated with bispecific antibody (BsAb) therapy in relapsed/refractory multiple myeloma (RRMM). Prophylactic IL-6 receptor blockade with tocilizumab ...
Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards [0.03%]
北方德国的精准肿瘤学——整合多组学和人工智能以支持循证分子肿瘤委员会
Jan Vorwerk,Lisa Leypoldt,Johanna Schwandt et al.
Jan Vorwerk et al.
The expanding availability of multi-omics profiling and advances in artificial intelli-gence (AI) and machine learning (ML) are changing precision oncology. Molecular testing strategies such as longitudinal liquid biopsy assessment, germlin...
Establishing a Multimodal Model for Predicting Lymphovascular Invasion in Breast Cancer Using Deep Transfer Learning Based on Ultrasound and Dynamic Contrast-Enhanced Magnetic Resonance Imaging [0.03%]
基于超声和动态对比增强磁共振成像的深度迁移学习预测乳腺癌淋巴管侵犯的多模态模型研究
Miaomiao He,Feifei Zhu,Feng Jiang et al.
Miaomiao He et al.
Objective: Develop a multimodal model based on ultrasound (US) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data for predicting lymphovascular invasion (LVI) in breast cancer. ...
Efficacy of Honey Combined with Cryotherapy in the Prevention and Management of Radiation-Induced Oral Mucositis in Patients Undergoing Concurrent Chemoradiotherapy for Head and Neck Cancer [0.03%]
蜂蜜联合冷疗在头颈癌同步放化疗患者放射性口腔黏膜炎预防和治疗中有效性的研究
Yuting Bao,Yajing Kan,Shuang Yang et al.
Yuting Bao et al.
Objective: To evaluate the preventive and therapeutic effects of honey combined with cryotherapy on radiation-induced oral mucositis (RTOM) in patients with head and neck cancer undergoing concurrent chemoradiotherapy, an...
Three therapeutic modalities for advanced ovarian cancer: real world data from a certified oncological center [0.03%]
三种晚期卵巢癌的治疗方法：来自一家认证肿瘤中心的实际数据
Sara Tato Varela,Walther Christian Kuhn
Sara Tato Varela
Introduction Traditionally, advanced ovarian cancer can be approached from two different therapeutic point of views: a radical surgery aimed at removing all macroscopic tumor followed by a systemic therapy (URS) or a neoadjuvant platinum-ba...
Real world experiences in the treatment of immune thrombocytopenia over a two-year period [0.03%]
一个两年期间免疫性血小板减少症治疗的现实世界经验
Geothy Chakupurakal,Karl Verpoort,Florian Kaiser et al.
Geothy Chakupurakal et al.
Introduction: ITP is an autoimmune disorder mostly treated in the outpatient setting. This study was conducted to analyze the real-world outcomes of outpatient care for ITP patients on treatment. ...
Safety and preliminary activity of neoadjuvant trastuzumab deruxtecan (T-DXd) plus 5-fluorouracil and folinic acid for HER2-positive, resectable esophagogastric adenocarcinoma: Results from the safety run-in cohort of the phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART trial [0.03%]
针对可切除食管胃结合部腺癌HER2阳性受试者使用T-DXd联合5-氟尿嘧啶和亚叶酸钙新辅助治疗的耐受性和初步疗效：Ib/II期NeoART试验安全导入组结果
Gertraud Stocker,Jack Chater,Thomas J Ettrich et al.
Gertraud Stocker et al.
Introduction: Despite advances in the multimodal treatment of resectable esophagogastric adenocarcinoma (EGA), relapse rates remain high. No human epidermal growth factor receptor 2 (HER2)-targeted treatment is yet establ...
Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer [0.03%]
2025年欧洲医学肿瘤学会年会泌尿系统肿瘤亮点：肾细胞癌和肌层浸润性膀胱癌的进展
Xin-Wen Zhang,Katrin Schlack,Arndt Hartmann et al.
Xin-Wen Zhang et al.
Several practice-relevant advances in genitourinary oncology were reported across renal cell carcinoma (RCC) and muscle-invasive bladder cancer (MIBC) at ESMO 2025. In localized RCC, the NESCIO study showed that short-course neoadjuvant che...
The Role of Regulatory Policies in Shaping Outpatient Cancer Treatment in Germany: A Comparative Perspective [0.03%]
德国监管政策在外科肿瘤治疗中的作用：比较视角下的门诊癌症治疗
Julia Heinen,Max Kraemer,Florian Kron et al.
Julia Heinen et al.
Introduction: The German healthcare system has traditionally separated sectors for inpatient and outpatient care. Recently, outpatient care was increasingly integrated into hospital settings, in particular for cancer pati...